US Patent 10981968 Fusion partners for peptide production
Patent 10981968 was granted and assigned to Pfenex Inc on April, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+264 characters)
Article
Patent abstract
The present invention relates to the field of medicine, in particular, to the production of large amounts of a soluble recombinant polypeptide as part of a fusion protein comprising an N-terminal fusion partner linked to the polypeptide of interest.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
109819680
Date of Patent
April 20, 2021
0Patent Application Number
161358750
Date Filed
September 19, 2018
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
109819680
Date of Patent
April 20, 2021
0Patent Application Number
161358750
Date Filed
September 19, 2018
0Official Website
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10981968 Fusion partners for peptide production
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10981968
Date of patent
April 20, 2021
Patent application number
16135875
Date Filed
September 19, 2018
Patent primary examiner
Find more entities like US Patent 10981968 Fusion partners for peptide production
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.